The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-[2-(3-Hydroxy-phenyl)-vinyl]-benzene-1,3-diol ID: ALA99852
Cas Number: 150258-84-7
PubChem CID: 10059651
Max Phase: Preclinical
Molecular Formula: C14H12O3
Molecular Weight: 228.25
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Synonyms: (E)-3,3',5'-Trihydroxystilbene | Trans-3,3',5-Trihydroxystilbene | 150258-84-7|CHEMBL99852|1,3-Benzenediol, 5-[(1E)-2-(3-hydroxyphenyl)ethenyl]-|(E)-5-(3-Hydroxystyryl)benzene-1,3-diol|3,5,3'-trihydroxystilbene|5-[(E)-2-(3-hydroxyphenyl)ethenyl]benzene-1,3-diol|SCHEMBL4742460|SCHEMBL4742462|Trans-3,3',5-Trihydroxystilbene|3,3',5-trihydroxy-trans-stilbene|(E)-3,3',5'-Trihydroxystilbene|BDBM50045922|AKOS040762881|5-[2-(3-Hydroxy-phenyl)-vinyl]-benzene-1,3-diol
Canonical SMILES: Oc1cccc(/C=C/c2cc(O)cc(O)c2)c1
Standard InChI: InChI=1S/C14H12O3/c15-12-3-1-2-10(6-12)4-5-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b5-4+
Standard InChI Key: QUGCFFKLKWANMQ-SNAWJCMRSA-N
Molfile:
RDKit 2D
17 18 0 0 0 0 0 0 0 0999 V2000
5.6167 -5.7000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0417 -6.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7917 -5.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1417 -5.7250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5500 -5.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5542 -6.4375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3750 -5.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3875 -6.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8667 -6.4000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2625 -5.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0875 -5.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1292 -4.2917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1417 -7.1500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4875 -4.9500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1042 -7.1000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2792 -7.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5125 -6.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 6 1 0
5 7 1 0
6 8 2 0
7 3 2 0
8 3 1 0
9 2 1 0
10 9 1 0
11 10 2 0
12 5 1 0
13 6 1 0
14 11 1 0
15 16 1 0
16 9 2 0
17 15 2 0
4 5 2 0
11 17 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 228.25Molecular Weight (Monoisotopic): 228.0786AlogP: 2.97#Rotatable Bonds: 2Polar Surface Area: 60.69Molecular Species: NEUTRALHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.47CX Basic pKa: ┄CX LogP: 3.40CX LogD: 3.37Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.69Np Likeness Score: 0.68
References 1. Thakkar K, Geahlen RL, Cushman M.. (1993) Synthesis and protein-tyrosine kinase inhibitory activity of polyhydroxylated stilbene analogues of piceatannol., 36 (20): [PMID:8411012 ] [10.1021/jm00072a015 ] 2. Albert S, Horbach R, Deising HB, Siewert B, Csuk R.. (2011) Synthesis and antimicrobial activity of (E) stilbene derivatives., 19 (17): [PMID:21803587 ] [10.1016/j.bmc.2011.07.015 ] 3. Wang G, Guo X, Chen H, Lin T, Xu Y, Chen Q, Liu J, Zeng J, Zhang XK, Yao X.. (2012) A resveratrol analog, phoyunbene B, induces G2/M cell cycle arrest and apoptosis in HepG2 liver cancer cells., 22 (5): [PMID:22326393 ] [10.1016/j.bmcl.2011.12.095 ] 4. Uzura S, Sekine-Suzuki E, Nakanishi I, Sonoda M, Tanimori S.. (2016) A facile and rapid access to resveratrol derivatives and their radioprotective activity., 26 (16): [PMID:27426305 ] [10.1016/j.bmcl.2016.07.018 ] 5. Nakao S, Mabuchi M, Wang S, Kogure Y, Shimizu T, Noguchi K, Tanaka A, Dai Y.. (2017) Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor., 27 (14): [PMID:28576617 ] [10.1016/j.bmcl.2017.05.025 ]